3 Stocks Shaking Up Health Care

In the preceding video, Fool.com analyst David Williamson discusses today's three top movers in the health-care sector. First up is Threshold Pharmaceuticals, down 12% as it appears likely to come in second to Celgenein the race to move competing pancreatic cancer drugs through phase 3 trials. Peregrine is another pharma in freefall, with shares down another 17% after already having lost 80% of its value in September. Finally, on the receiving end of some good news in this space is Novavax, up 8% today on no specific news, and up 35% YTD.

One recent success story in the do-or-die biotech industry is Arena Pharmaceuticals. After gaining FDA approval for its innovative obesity drug, the future is looking bright, although there are still plenty of obstacles ahead for the company. In our brand-new premium research report on Arena Pharmaceuticals, we walk investors through the must-know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of free updates for those who sign up. To learn more and access your report today, click here now.

The article 3 Stocks Shaking Up Health Care originally appeared on Fool.com.

Dave Williamson and The Motley Fool have no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.